This has been revised by Dexcom. The new inserter will be launched as part of the G6 system.
Dexcom Earnings Call for second quarter 2017
August 1, 2017
Kevin Sayer, CEO of DexCom
"With respect to our product pipeline, we continue to have regular interactions with the FDA. Our G6 pivotal study is complete, and we plan to submit our PMA by the end of the third quarter. As we have referenced in a number of our recent updates, because of the progress we are making on our G6 submission, we have assessed our launch timing for the new applicator configuration with G5 compared to a full G6 launch and have made the decision to withdraw our FDA filing for the new insertion system in the G5 configuration.
The gap between the launch of this G5 configuration and G6 continues to narrow, reaching a point where the operational strain associated with launching a new applicator and sensor platform less than a year apart no longer makes strategic sense."
… clip …
“We have a new receiver we’re launching here in the fall that will be here for the patients.”
(While not mentioned in THIS call specifically as “touchscreen” the only logical conclusion with a “new” receiver is actually the “touchscreen” receiver such that one would assume the CEO is confirming the 2017 Fall launch of the G5 touchscreen receiver)